Jinming Zhou | Medicinal Chemistry | Best Researcher Award

Dr. Jinming Zhou | Medicinal Chemistry| Best Researcher Award

Research and Grant Success:

  • Dr. Zhou’s research has been consistently supported by prestigious National Natural Science Foundation (NCSF) grants, with four approvals to date. This grant success not only reflects the high quality and impact of his research but also indicates his capacity to conduct rigorous and relevant studies that address critical health challenges.
Dr. Jinming Zhou, Zhejiang Normal University , China

Profile

Scopus

OrcID

🌱EARLY ACADEMIC PURSUITS

  • Dr. Zhou’s academic journey began at Beijing Normal University, where he earned his Bachelor of Science (B.S.) in 2000 and Master of Science (M.S.) in 2003. His passion for rational drug design led him to pursue a Ph.D. at the Shanghai Institute of Organic Chemistry, where he specialized in this field, establishing a strong foundation in medicinal chemistry. Postdoctoral training followed at McGill University in Canada, where he continued advancing in rational drug design and gained international research exposure.

💼 PROFESSIONAL ENDEAVORS

  • In 2010, Dr. Zhou joined the Institute of Medicinal Biotechnology at the Chinese Academy of Medical Science as an Associate Professor. Demonstrating outstanding contributions in drug research, he achieved full professorship in 2017. His career took a new turn in 2018 when he accepted a professorship at Zhejiang Normal University, where he also became the Director of the Drug Development and Innovation Center. Dr. Zhou’s leadership at this center has been pivotal in establishing innovative practices and groundbreaking projects.

🔬CONTRIBUTIONS AND RESEARCH FOCUS 

  • Dr. Zhou’s research team is at the forefront of developing anti-viral and anti-cancer drugs. His group combines rational drug design and applied medicinal research to create effective therapeutic solutions. His work has a special emphasis on translational medicine, aiming to bridge scientific research and clinical applications. He has secured four prestigious National Natural Science Foundation (NCSF) grants, supporting his work in advancing therapeutic drug development.

📚ACADEMIC CITES 

  • With over a hundred publications, Dr. Zhou has significantly impacted medicinal chemistry, particularly in antiviral and anticancer drug design. His research has become a widely cited reference in related studies, underscoring his scientific contributions’ value and relevance.

🌍IMPACT AND INFLUENCE

  • Dr. Zhou’s influence in the medicinal chemistry field is highlighted by his 100+ publications in high-impact journals, showcasing the scientific community’s recognition of his expertise. His achievements were honored in 2012 with the prestigious “Xiehe Star” award, recognizing his exceptional contributions to the field of drug design.

🌟LEGACY AND FUTURE AND CONTRIBUTIONS

  • As Dr. Zhou continues his work at the Drug Development and Innovation Center, he is shaping a new generation of researchers focused on tackling global health challenges. His legacy is built not only on his published works but also on his mentorship and role in expanding the field of drug innovation. His ongoing research promises to further the understanding of rational drug design and its applications in combating complex diseases.

📄Publications

  • “Inducing or enhancing protein-protein interaction to develop drugs: Molecular glues with various biological activity”
    Authors: Zhang, R., Zheng, Y., Xiang, F., Zhou, J.
    Journal: European Journal of Medicinal Chemistry, 2024, 277, 116756
  • “METTL3 inhibitor suppresses the progression of prostate cancer via IGFBP3/AKT pathway and synergizes with PARP inhibitor”
    Authors: Chen, X., Wang, M., Wang, H., Zhou, J., Wu, M.
    Journal: Biomedicine and Pharmacotherapy, 2024, 179, 117366
  • “Autophagy mediated targeting degradation, a promising strategy in drug development”
    Authors: Zhang, J., Pan, X., Ji, W., Zhou, J.
    Journal: Bioorganic Chemistry, 2024, 149, 107466
  • “A novel hydrophobic tag leads to the efficient degradation of programmed death-ligand 1”
    Authors: Gao, J., Xie, Y., Zhang, J., Cen, S., Zhou, J.
    Journal: RSC Medicinal Chemistry, 2024, 15(9), pp. 3038–3047
  • “Design and Synthesis of Dual-Target Inhibitors Targeting Androgen Receptors and Glucocorticoid Receptors to Overcome Antiandrogen Resistance in Castration-Resistant Prostate Cancer”
    Authors: Li, C., Han, X., Yan, Q., Wu, M., Zhou, J.
    Journal: Journal of Medicinal Chemistry, 2024, 67(5), pp. 3419–3436

Qiang Liu | Organic Chemistry | Best Researcher Award

Assoc Prof Dr. Qiang Liu | Organic Chemistry | Best Researcher Award

Collaborative Research and Mentorship:
  • Dr. Liu has a successful history of collaborations, such as his work with Yu Lan, and supervises PhD students, contributing to the growth of young scientists. His collaborative approach strengthens his scientific network and broadens the impact of his research.
Assoc Prof Dr. Qiang Liu , Tsinghua University, China

Profile

Scopus

OrcID

🏛️Early Academic Pursuits

  • Qiang Liu’s academic journey began at Wuhan University, where he earned both his Bachelor’s degree (2007) and Doctorate (2012) from the College of Chemistry and Molecular Sciences. Under the supervision of Prof. Aiwen Lei, his doctoral studies laid the foundation for his later work in metal catalysis and hydride transfer reactions. Following his PhD, Liu expanded his research horizons through a prestigious postdoctoral stint at the Leibniz Institute for Catalysis in Germany, where he worked under the guidance of Prof. Matthias Beller, a world-renowned expert in catalysis.

👨‍🔬 PROFESSIONAL ENDEAVORS

  • In July 2015, Qiang Liu began his independent research career at Tsinghua University, one of China’s top institutions, where he rapidly advanced to the position of tenured Associate Professor and Vice-Chair of the Chemistry Department. His research has consistently been supported by high-profile funding, enabling the successful completion of 11 major research projects. Liu has established collaborations with notable scientists like Yu Lan, contributing to both academic and industry-related consultancy projects.

🏆 CONTRIBUTIONS AND RESEARCH FOCUS

  • Qiang Liu’s primary research focus is the structure, properties, and catalysis of metal-hydride intermediates derived from abundant metals. His work seeks to replace costly, precious metal catalysts with more sustainable, earth-abundant alternatives. Liu’s innovative bimetallic anionic hydride catalysis represents a significant breakthrough, enabling highly selective and efficient (de)hydrogenation reactions. His research has broad applications, from green synthesis to biomass conversion and chemical hydrogen storage.

📊 IMPACT AND INFLUENCE

  • Liu’s work has had a profound impact on the fields of synthetic chemistry and catalysis. His discovery of novel metal hydride systems has opened new avenues for sustainable chemical reactions, positioning him as a leading figure in catalysis research. With 85 peer-reviewed journal articles, including publications in high-impact journals, and an impressive citation index of 9325 with an H-index of 42, his influence continues to grow globally. Liu’s editorial appointments with esteemed journals such as Green Synthesis and Catalysis and the Asian Journal of Organic Chemistry further showcase his leadership within the scientific community.

🏅ACADEMIC CITES

  • With over 9325 citations and an H-index of 42, Qiang Liu’s research has gained substantial recognition. His contributions have consistently been cited in both theoretical and applied catalysis research, underscoring the significance of his work in advancing green chemistry. He has authored and co-authored 85 scientific papers, and his work is frequently referenced by peers aiming to develop more efficient, environmentally friendly catalytic processes.

🚀LEGACY AND FUTURE CONTRIBUTIONS

  • Qiang Liu’s research is paving the way for the future of sustainable chemistry, especially in the areas of biomass conversion and hydrogen storage. His goal is to continue exploring the synergistic interactions between metal hydrides and other catalytic systems to achieve enzyme-like efficiency. With 13 patents and ongoing innovation in metal catalysis, Liu’s work is expected to have a lasting legacy in both academic and industrial sectors. He remains committed to pushing the boundaries of green synthesis and catalysis, with a long-term vision of reducing reliance on precious metals and developing cost-effective, scalable catalytic systems

📄Publications

  • Unveiling the Unique Reactivity of Anionic Mn(I) Complexes via Metal-Ligand Cooperation: Nucleophilic Attack on C(sp3)-X Bonds
    Authors: H. Li, M. Fan, Q. Liu
    Journal: Journal of the American Chemical Society
  • Asymmetric Hydrogenation of Ketimines with Minimally Different Alkyl Groups
    Authors: M. Wang, S. Liu, H. Liu, Y. Lan, Q. Liu
    Journal: Nature
  • Enhancing Hydride Transfer in Catalytic Hydrogenation via σ-Electron-Induced Polarization of Imines
    Authors: S. Liu, H. Yang, Y.-N. Wang, Q. Liu, Y. Lan
    Journal: Journal of the American Chemical Society
  • Manganese-Catalyzed Regioselective Hydroboration of Quinolines via Metal–Ligand Cooperation
    Authors: Y. Wang, H. Li, H. Yang, M. Fan, Q. Liu
    Journal: CCS Chemistry
  • Synergistic Pd/Cu-Catalyzed 1,5-Double Chiral Inductions | 钯/铜双金属协同催化构建 1,5-双手性中心
    Authors: H. Huang, Q. Liu
    Journal: Chinese Journal of Organic Chemistry